Key Takeaways
- Guidance floor raised, margin streak intact: Constant-currency revenue guidance lower end lifted to 10.5% (from 10%) while EBIT margin expanded for the eighth straight quarter to 12.5%, absorbing wage hikes and 3,000 people onboarded largely ahead of revenue.
- BFS is carrying the quarter: BFS grew 19% YoY and 9% sequential in constant currency, driven by broad-based demand and execution on a large engagement won a few quarters ago; other verticals did not significantly contribute.
- Healthcare hit a timing air pocket: The vertical declined 2% sequential as payer programs recalibrated after CMS rate adjustments and a transformative BPaaS engagement wound down, but four new logos and the HR1 catalyst on the provider side set up a second-half recovery.
- The productization thesis is now in production: Outbound voice AI agent stack and DenialsAI platform are live at scale, the intelligent context framework is attached to nearly 50% of top-50 clients, and management is explicitly targeting operating leverage from repeatable solutions.
- What to watch next quarter: Whether the four variables backing the “H2 stronger than H1” call (large deal ramps, banking client transition, 17 new logos, best-ever pipeline) actually convert into broad-based growth beyond BFS, and whether healthcare’s sequential decline reverses.
BFS: The Engine That Delivered the Quarter
- Broad-based demand: Consumer debt levels and servicing complexity kept demand high across the BFS portfolio, while cost pressure kept clients focused on efficiency and outsourcing.
- Large engagement execution: Much of the headcount added in Q2 went into delivery commitments for a large BFS engagement won a few quarters ago, and the ramp is proceeding as planned.
- Major banking client transition: Most of the people onboarding for a major banking client was completed in Q2, ahead of revenue, setting up a contribution that should flow through in H2.
- Margin dip dismissed: A slight dip in the BFSI margin profile drew an analyst question; management said not to read into quarter-by-quarter aberrations and saw no cause for concern.
Healthcare: A Pause, Not a Reversal
- Sequential decline explained: Healthcare declined 2% sequential in constant currency, reflecting timing of certain program ramps and transitions rather than demand weakness.
- Payer-side recalibration: Medicare Advantage clients recalibrated scope after CMS rate adjustments, creating a timing challenge that depressed the quarter; the wind-down of a transformative payer BPaaS engagement is now largely behind.
- Provider-side tailwind building: Flat reimbursement, rising labor costs, and HR1 changes are accelerating a structural shift to AI and automation-led revenue cycle management, where Firstsource’s DenialsAI platform and outcome-based RCM are positioned to capture share.
- HR1 catalyst is concrete: From January 2027, Medicaid renewals for expansion adults move from annual to six-monthly, phasing in through the year; Firstsource already runs Medicaid eligibility at scale, so this extends an existing operation rather than requiring a new build.
- Four new logos added: Healthcare added four new logos in Q2, and management expects contributions from these, account expansions, and the HR1 opportunity to drive a recovery.
Productization & AI: The Operating-Leverage Bet
- Production-scale deployments: The outbound voice AI agent stack and DenialsAI platform are now in production at scale, giving Firstsource leverage with provider clients and a demonstrable proof point for the productized-services thesis.
- Intelligent context framework: Attached to almost 50% of the top 50 clients, the framework provides insights that open doors for further opportunities and deepen account relationships.
- Productized services economics: Management explicitly called out the operating-leverage advantage: a productized service makes the second implementation cheaper than the first, and the third cheaper than the second, breaking the traditional services fallacy where every implementation costs nearly as much as the first.
- Three indicators to watch: Management laid out its own scorecard: repeatability of solutions across clients, evolution of revenue mix toward non-linear and outcome-based models, and disciplined measurement with clear baselines and tangible outcomes.
- AI-native start-up partnerships: One large deal from a new logo was won on the back of an AI-native start-up partner referencing Firstsource as its preferred partner, a model management called “much more symbiotic” than traditional competitor dynamics.
Idnani: “The traditional fallacy of the services business has been that the second implementation costs nearly as much as the first one, and so you don't get any operating leverage. A productized services allows you to recoup some of that because the second implementation should be cheaper than the first one.”
Margins: Structural Expansion Absorbing Investment
- Eighth straight quarter of expansion: EBIT margin rose 10 bps QoQ and 100 bps YoY to 12.5%, despite absorbing the first phase of annual wage increments and the cost of onboarding 3,000 people largely ahead of revenue.
- Structural drivers, not one-offs: Margin expansion is broad-based, driven by right-shoring (80% of gross hiring offshore or near-shore, with India and the Philippines accounting for 85% of Q2 additions), productivity from AI and automation in existing accounts, non-linear pricing (more than 50% of business), and portfolio quality improvement.
- Headcount and cost decoupled: Headcount increased roughly 3,000 in Q2 but employee cost rose only 3% QoQ, because additions for growth were offset by headcount optimization and inefficiency reduction; management stressed this is not a linear relationship and that looking at it on a single quarter basis may not give the right inference.
- Medium-term ambition: Management expects 50 to 75 bps of annual margin improvement to continue, targeting a 14% to 15% EBIT margin band over the next two to three years.
- Reinvestment is deliberate: Margin gains are being consciously reinvested into capabilities and talent to build a durable firm for the future, not just for the next several quarters; management framed this as essential to having a business that remains relevant five to ten years out.
Idnani: “I'm a firm believer that if we don't reinvest in capabilities and get in talent which might be different from how firms like ours would have looked 5, 10 years ago, we would not have a business for the future.”
Large Deals & Pipeline: The H2 Case
- Seventh straight quarter of four or more large deals: Four large deals signed in Q2, two from new logos, continuing a trajectory that has stepped up from roughly two per quarter to roughly three, and now to roughly four for seven consecutive quarters.
- Ambition to raise the bar: Management is pushing the sales organization to increase the pipeline and number of large deals from four to a larger number, such as five or six per quarter.
- New logo momentum: 17 new logos added in Q2, one of the highest quarterly additions, including six strategic logos; the broadening base has reduced the revenue share of the top 5 and top 10 clients by 6 and 10 percentage points respectively over eight quarters, even as those large clients continue to grow at the industry rate.
- Client cohort feeding system: Clients above USD 1 million in revenue are up 32% over two years, and each cohort is designed to feed the next; 51 clients are now above the USD 5 million run rate, almost double versus two years ago.
- Pipeline at its best ever: Management cited the pipeline as one of four variables underpinning the expectation that H2 will be stronger than H1, alongside large deal ramps, the banking client transition, and the 17 new logos.
- Renewal strategy: In existing customer renewals where deflation hits existing scope, Firstsource has been able to maintain the revenue base at neutral by taking on other pieces of work.
Vertical & Geographic Mix
| Vertical / Region | Trend | Commentary |
|---|---|---|
| BFS | ▲ Strong growth | 19% YoY, 9% sequential CC; broad-based demand, large engagement ramp, banking client transition completed. |
| Healthcare | ▼ Sequential decline | Down 2% QoQ CC on payer program timing and BPaaS wind-down; four new logos and HR1 catalyst set up H2 recovery. |
| CMT | ▬ Flat sequential | Flat QoQ CC; quarter-to-quarter volatility driven by work-packet timing and program transitions within the consumer tech portfolio; healthy pipeline across telecom, cable, media, technology, and digital-native clients. |
| Europe | ▲ Strong growth | 27% YoY, 7% sequential CC, led by BFS with good momentum in CMT; two large wins secured during the quarter. |
| Australia | ▲ Strong growth | 50% YoY, supported by continued momentum across existing relationships and a steadily improving pipeline. |
| North America | ▬ Steady | Healthy pipeline maintained; management confident in medium-term growth outlook. |
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY27 constant-currency revenue growth | 10.5% to 13% (lower end raised from 10%) | FY27 |
| FY27 EBIT margin | 12.25% to 12.75% (reaffirmed) | FY27 |
| H2 stronger than H1 | Based on large deal ramps, banking client transition, 17 new logos, and best-ever pipeline | H2 FY27 |
| Senior-level wage hikes | Factored into EBIT forecasts; expect to remain within guidance | Q3 FY27 |
| Effective tax rate | 22% to 24% | FY27 |
| Medium-term EBIT margin band | 14% to 15% | Next 2–3 years |
| Large deal cadence ambition | Increase from four to five or six per quarter | No date (push underway) |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | ₹2,830 cr, up 22.2% YoY and 3.7% QoQ |
| Revenue (USD) | US$296 million, up 11.7% YoY and 2.6% QoQ |
| Constant currency revenue growth | 12.3% YoY, 2% QoQ |
| EBIT | ₹350 cr, up 32.2% YoY |
| EBIT margin | 12.5%, up 100 bps YoY and 10 bps QoQ; eighth straight quarter of sequential margin expansion |
| Net profit | ₹230 cr, up 29.7% YoY and 4.8% QoQ on normalized basis |
| Diluted EPS | ₹3.31 |
| H1 FY27 revenue | ₹5,550 cr (US$584 million), constant currency growth of 12.3% YoY |
| H1 FY27 EBIT | ₹690 cr, up 33.4% YoY, margin 12.4% |
| H1 FY27 adjusted PAT | ₹450 cr, up 30.4% YoY |
| FY27 constant currency revenue growth guidance | 10.5% to 13%, raised from 10% to 13% |
| FY27 EBIT margin guidance | 12.25% to 12.75%, reaffirmed |
| Large deals signed | 4, ACV over US$5 million each; seventh straight quarter of four or more; 2 from new logos |
| New logos added | 17, including 6 strategic logos (potential ≥US$5 million annual revenue each) |
| Headcount | 39,937, net increase of 3,062 during the quarter; India and Philippines accounted for over 85% of the increase |
| Voluntary attrition (tenure >180 days) | 28.4% on trailing 12-month basis |
| Clients with >$5 million revenue run rate | 51, up 6 QoQ; largest sequential addition in this cohort organically in over 5 quarters |
| Clients with >$10 million revenue run rate | 23, up 3 QoQ |
| BFS vertical constant currency growth | 19% YoY, 9% sequential; 9 new logos |
| Healthcare vertical constant currency growth | 5% YoY, -2% sequential; 4 new logos |
| CMT vertical constant currency growth | 6% YoY, flat sequential; 2 new logos |
| Diverse portfolio (utilities + retail) constant currency growth | 25% YoY, flat sequential; 2 new logos |
| North America constant currency growth | 6% YoY, 1% sequential |
| Europe constant currency growth | 27% YoY, 7% sequential |
| Australia constant currency growth | 50% YoY |
| Non-linear revenue share | More than 50% of total revenues |
| Cash and bank balance | ₹410 cr |
| Net debt | ₹1,530 cr, down from ₹1,710 cr at end of June 2026 |
| Normalized DSO | 67 to 69 days |
| Q2 FCF to PAT | 150% |
| H1 FCF to PAT | 126% |
| H1 FY27 effective tax rate | 23.2%; FY27 expected range 22% to 24% |
| Hedge book | GBP 6.92 cr coverage for next 12 months at avg rate ₹116.6/GBP; USD 6.85 cr coverage at avg rate ₹95.7/USD |